(Alliance News) - GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secondary target. The First-Engot-OV44 phase III trial evaluated ...

LONDON, UK I, 2024 I GSK plc (LSE/NYSE: GSK) today announced headline results from the FIRST-ENGOT-OV44 phase III trial evaluating Zejula ...

Teva Pharmaceutical Industries Ltd. ADR 0.52% $23.98B ...

London stocks had fallen further by midday on Friday as investors mulled a smaller-than-expected rise in retail sales but ...

Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug ...

Novo Nordisk said on Friday its experimental next-generation obesity drug CagriSema helped overweight patients cut their ...

London stocks looked set for more losses at the open on Friday as investors mulled a smaller-than-expected rise in retail ...

(Sharecast News) - London stocks ended the day on a mixed note Friday, as investors weighed weaker-than-expected UK retail sales growth and cooler US price growth than anticipated. The FTSE 100 index ...

Here is what you need to know at the London market open: According to the Office for National Statistics ... 6.4 million ordinary shares of 20 pence each were repurchased for a total consideration of ...

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...

Make’s redevelopment proposals for the former ITV Studios on London’s South Bank have been given the go-ahead in the High ...

The London Festival of Architecture (LFA) has named the winner of its contest to design a £2 million upgrade of Battersea’s Falcon Road Bridge ...